Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
axium
Press Release
Aug 14, 2017
IPO Rumor: Axium Pharmaceuticals
Axium Pharmaceuticals Inc. the creator of the drug Truveta for the treatment of epilepsy is rumored to be in the beginning stages of an IPO.
Read More
Press Release
Jun 29, 2017
Treating Epilepsy — The Next Big Thing
The FDA has accepted an orphan designation request for use of TRUVETA submitted by Axium Pharmaceuticals Inc.
Read More
First
Prev
1
Next
Last
